GF Fund Management
ONC icon

GF Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

GF Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$232K Sell
635
-45
-7% -$15.4K ﹤0.01% 268
2026
Q2 		$194K Sell
680
-27
-4% -$7.96K ﹤0.01% 279
2026
Q1 		$210K Buy
707
+90
+15% +$29.1K ﹤0.01% 281
2025
Q4 		$187K Sell
617
-106
-15% -$34.7K ﹤0.01% 302
2025
Q3 		$246K Sell
723
-412
-36% -$125K ﹤0.01% 269
2025
Q2 		$275K Hold
1,135
– – 0.01% 294
2025
Q1 		$309K Buy
+1,135
New +$265K 0.01% 289

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

GF Fund Management's ONC Position: Q3 2026 in Review

GF Fund Management reduced its BeOne Medicines Ltd (ONC) stake by 6.6% in Q3 2026, selling an estimated $15.4K and leaving 635 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

GF Fund Management first reported a position in ONC in Q1 2025 and has held it in 7 quarters since. The position peaked at $309K in Q1 2025. 168 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • GF Fund Management held 635 shares of BeOne Medicines Ltd worth $232K as of Q3 2026.
  • GF Fund Management sold 45 BeOne Medicines Ltd shares in Q3 2026, an estimated $15.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #268 holding.
  • GF Fund Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 7 quarters since.
  • GF Fund Management's BeOne Medicines Ltd position peaked at $309K in Q1 2025.
  • 168 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.